4 Results for "

Carminomycin

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Carminomycin" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B2171A
CAS No.: 52794-97-5
Synonyms: Carminomycin hydrochloride; Carminomicin I hydrochloride
Carubicin hydrochloride is a microbially-derived compound. Carubicin hydrochloride is an effective inhibitor of VHL-defective (VHL−/−) CCRCC cell proliferation. Carubicin hydrochloride also induces apoptosis by a mechanism independent of p53 or hypoxia-inducible factor HIF2. Carubicin hydrochloride has the potential for the research of cancer diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B2171
CAS No.: 50935-04-1
Synonyms: Carminomycin; Carminomicin I
Carubicin (Carminomycin) is a microbially-derived compound. Carubicin is an effective inhibitor of VHL-defective (VHL−/−) CCRCC cell proliferation. Carubicin also induces apoptosis by a mechanism independent of p53 or hypoxia-inducible factor HIF2. Carubicin has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-B2171AR
CAS No.: 52794-97-5
Synonyms: Carminomycin hydrochloride (Standard); Carminomicin I hydrochloride (Standard)
Carubicin hydrochloride (Standard) (Carminomycin hydrochloride (Standard)) is the analytical standard of Carubicin hydrochloride (HY-B2171A). This product is intended for research and analytical applications. Carubicin hydrochloride is a microbially-derived compound. Carubicin hydrochloride is an effective inhibitor of VHL-defective (VHL?/?) CCRCC cell proliferation. Carubicin hydrochloride also induces apoptosis by a mechanism independent of p53 or hypoxia-inducible factor HIF2. Carubicin hydrochloride has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-135176
CAS No.: 62182-86-9
13-Dihydrocarminomycin (compound D788-12) is the major metabolite of the antitumor antibiotic Carminomycin (HY-B2171). 13-Dihydrocarminomycin has weak antitumor activity .
loading...
    loading...